Company profile

MOMM Diagnostics GmbH

MOMM Diagnostics is developing préXclude, a revolutionary rapid preeclampsia test – the quickest and most accurate way to detect preeclampsia in pregnant women. Our test delivers results in just minutes, making it ideal for use in hospitals, clinics, and even at home. Preeclampsia is a serious and potentially life-threatening condition that affects up to 8% of pregnancies. With our test, early detection is possible, allowing for prompt medical intervention and better outcomes for both mother and baby.

More news about MOMM Diagnostics GmbH

01.12.2023 09:00

Four startups to explore South Africa’s health challenges

Please login or
register to use the
awards follow feature
13.11.2023 12:53

Strong Swiss delegation at Medica Startup Park

Please login or
register to use the
awards follow feature
03.05.2023 09:00

New bearers of the Innosuisse Certificate ready for the next level

Please login or
register to use the
awards follow feature
23.04.2021 09:20

Tech4Eva draws global interest

Please login or
register to use the
awards follow feature
MOMM Diagnostics GmbH

Founded
2018

Kanton
Basel-Stadt


LinkedIn

Homepage

rss